Drug Discovery World
JULY 5, 2023
Key features of the Summer issue include a market report on India’s drug discovery sector, advancing treatments in Alzheimer’s, and whether big data can chart a new path to drug discovery and development Exclusive Guide on Therapeutic Antibodies This issue contains an exclusive Guide on Therapeutic Antibodies , covering the latest innovations (..)
XTalks
OCTOBER 18, 2022
Using the big data from our HFX Cloud patient database, our unique HFX Algorithm was developed to identify those programs where patients have been more likely to get relief in the real world. Keith Grossman, chairman and CEO of Nevro, in a company press release. Pain is variable from patient to patient and over time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
MAY 25, 2021
A recent pharmaphorum webinar , held in partnership with Savana and BREATHE – the Health Data Research Hub for Respiratory Health, heard that RWE is also accelerating the development of new and innovative therapies and treatments to improve patient outcomes. The benefits of RWE. About Savana.
pharmaphorum
FEBRUARY 11, 2022
Sun says Komodo’s Healthcare Map has been built over the last seven and a half years and contains so much information that can help identify and treat patients with rare diseases. Instead, Komodo’s software is the gateway to the Map’s data. The business of data. Our software is deployed across two dimensions.
The Pharma Data
JANUARY 31, 2021
is an agricultural bioscience company developing crop innovations aligned with trends in global food security, social responsibility, and sustainability. Yield10 assumes no obligation to update any forward-looking information contained in this press release or with respect to the matters described herein. Yield10 Bioscience, Inc.
The Pharma Data
JANUARY 4, 2021
Kiromic’s deep understanding of the tumor micro environment (TME) and the tumors’ escape and masking mechanisms led to development of a promising platform for chimeric antigen receptor therapy (CAR-T). PD-1 has always been a challenge for CAR-T development. “We believe Prof. About PD-1 Check-point inhibition.
Drug Discovery World
SEPTEMBER 5, 2022
Throughout the continuum of drug development, from target discovery to patient selection, machine learning approaches are being adopted to reliably mine vast amounts of data and make predictions with higher accuracy Anita Ramanathan discusses how machine learning is currently used across different stages of cancer research. .
Expert insights. Personalized for you.
96 
Let's personalize your content